The ALIVE Charity Foundation has donated €100,000 to the Research Trust (RIDT) of the University of Malta for Cancer Research.

This was the fifth major donation by the foundation in the past five years. It has so far financed three PhD and one Master scholarships in cancer research at the University of Malta.

The donation was made by Nicky Camilleri, president of ALIVE Charity Foundation, to Prof. Saviour Zammit, pro-rector of the University of Malta, and Trustee of the RIDT during a ceremony in which the RE/MAX ALIVE 2018 Cycling Challenge for Cancer was also launched.

The event was held at San Anton Palace in the presence of President Marie-Louise Coleiro Preca.

RE/MAX ALIVE 2018 will bring together around 50 cyclists who will be participating in a 1200km epic Trans-Alp cycling challenge between July 19 and 28.

The group will cycle some 170 km every day for seven days, from Vienna to Salzburg, through the Brenner Pass, along Lake Garda to Milan. The participants have a choice of two routes to choose from, either Road or trails for those who prefer off road. The two routes run in parallel giving a chance to the participants to meet together and exchange their experiences at intervals during the day.

This year the RE/MAX ALIVE2018 Cycling Challenge for Cancer will start promoting the challenge internationally to encourage cyclists from all over the world to take part and raise funds for local medical cancer research.

Wilfred Kenely, CEO of RIDT expressed his gratitude to ALIVE for their support and underlined the increase in cancer research that has been made possible as a result of the sustained support of these cyclists who embark on a tough challenge every year to raise funds that allows academics to continue with their cancer research.

Nicky Camilleri stressed that the Foundation set out to make a difference in the community and the efforts of so many like-minded individuals led to more than half a million euros being raised towards cancer research. 

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.